Cargando…
Cushing Syndrome Associated Myopathy: It Is Time for a Change
Cushing syndrome is the result of excessive levels of glucocorticoids. Endogenous Cushing syndrome is rare with an incidence of two to three cases per million per year. Clinically, the presentation consists of a characteristic phenotype including skin symptoms and metabolic manifestations. A frequen...
Autor principal: | Reincke, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Endocrine Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258338/ https://www.ncbi.nlm.nih.gov/pubmed/34139801 http://dx.doi.org/10.3803/EnM.2021.1069 |
Ejemplares similares
-
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of Cushing's syndrome
por: Newell-Price, John, et al.
Publicado: (2020) -
Chemosensory dysfunction in Cushing’s syndrome
por: Heger, Elena, et al.
Publicado: (2021) -
Toward a Diagnostic Score in Cushing's Syndrome
por: Braun, Leah T., et al.
Publicado: (2019) -
Genomics in Cushing’s Disease: The Dawn of a New Era
por: Reincke, Martin, et al.
Publicado: (2021) -
Genetics of Cushing’s disease: from the lab to clinical practice
por: Theodoropoulou, Marily, et al.
Publicado: (2022)